SEC Filing Summary: Form 8-K
Business Context and Reporting Period
Company: AspenBio Pharma, Inc. (Note: Request metadata listed "Riot Platforms, Inc.", but the filing text identifies the registrant as AspenBio Pharma, Inc.)
Reporting Date: January 3, 2007
Event: Issuance of a press release regarding Results of Operations and Financial Condition (Item 2.02) and Regulation FD Disclosure (Item 7.01).
Location: Castle Rock, Colorado
Key Financial Metrics
The filing text provided is a cover sheet and does not contain specific financial data. The actual results are contained in the press release attached as Exhibit 99.1, which is not included in the input text. Consequently, the following metrics are not available in the source document:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing indicates that material information regarding the company's results of operations and financial condition was disclosed via a press release on January 3, 2007. Specific details regarding changes versus prior periods are not present in the provided text.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) but does not include the text of the commentary, guidance, or outlook.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Verify Exhibit 99.1: Investors must locate and review the attached press release to obtain actual financial figures and management commentary.
- Confirm Company Identity: Ensure analysis is applied to AspenBio Pharma, Inc., as the filing text contradicts the "Riot Platforms, Inc." name in the request metadata.
- Check Historical Context: Review prior period filings to compare against the results mentioned in the January 3, 2007 press release.